FDA Modernization Act 3.0

The House debated H.R. 2821, the FDA Modernization Act 3.0, which requires the FDA to issue a rule updating its drug-testing regulations to reference modern, non-animal testing methods in place of animal tests. Members from both parties spoke in support: Representative Buddy Carter, who introduced the bill, said it would make the FDA follow through on allowing alternatives to animal testing, reducing animal suffering and helping new medicines reach patients faster. Representative Troy Carter, a Democratic co-lead, noted that Congress had already authorized such alternatives but the FDA had not yet updated its rules, and said this bill directs the agency to write them. The debate was brief and the bill had bipartisan backing, with no opposing points recorded in the discussion.Written by AI from the debate. Updated 2026-10-17.

Official text ↗(opens in a new tab)